Assistance in Neurosurgery (ExtempoRMN)
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Glioma
Related studies linked through entity extraction aliases.
Safety of BBB Opening With the SonoCloud
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Molecular-Guided Therapy for Childhood Cancer
- Status
- COMPLETED
- Phase
- NA
Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
- Status
- COMPLETED
- Phase
- PHASE1
5-ALA in Recurrent Glioma
- Status
- UNKNOWN
- Phase
- NA
Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Improving Ultrasound Images in Brain Tumor Surgery With the Use of Brain Mimicking Fluid
- Status
- COMPLETED
- Phase
- PHASE1
Hypofractionated Imrt (Vmat-Ra) For Elderly Patients With Newly Diagnosed High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Hypofractionated IMRT With Temozolomide for HGG
- Status
- COMPLETED
- Phase
- NA
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
- Status
- COMPLETED
- Phase
- PHASE1
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
- Status
- TERMINATED
- Phase
- PHASE1
Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)
- Status
- COMPLETED
- Phase
- NA
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
- Status
- TERMINATED
- Phase
- PHASE2
ANG1005 in Patients With Recurrent High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2